Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q4 2019 13F Holders as of 31 Dec 2019

Security identity
Shares outstanding
313,041,907
Holder snapshot
Share change
-7,211,336
Put/Call ratio
24950%
Reported price per share
$4.82
Number of holders
116
Value change
-$9,606,036
Number of buys
72
Number of sells
46

Security key

03168L105

Report period

Q4 2019

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Fosun International Ltd
13D/G signal
Evidence rows
15
Latest as of
30 Sep 2019
13F Lead comparable stake: 6.9% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Fosun International Ltd
13F
Company
13F
6.9%
$62,412,000
21,521,301 shares
30 Sep 2019
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
13F
5.2%
$47,019,000
16,213,367 shares
30 Sep 2019
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
5.1%
$46,088,000
15,892,389 shares
30 Sep 2019
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
3.6%
$32,722,000
11,283,585 shares
30 Sep 2019
VANGUARD GROUP INC
13F
Company
13F
3%
$27,462,000
9,469,734 shares
30 Sep 2019
BlackRock Finance, Inc.
13F
Company
13F
2.4%
$21,831,000
7,528,050 shares
30 Sep 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
101,152,211
Rows available
116
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
111
Q4 2019 holders
116
Holder diff
5
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 value Q4 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .